Kinaset Therapeutics Appoints Christopher O'Brien, MD, PhD, FCCP, as Chief Medical Officer
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Stay updated with breaking news from Roger Heerman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
The problem Kinaset is trying to solve is that over time, patients receiving asthma therapies – typically inhaled corticosteroids plus bronchodilators – become steroid-refractory.